Lupron depot-PED 11.25 MG 3MOS
Ended Awarded Last action
- Contract number
- SPE2DR26F9R07
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,935
Award facts
- Contract value 100% obligated
- $23,934.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Lupron Depot-Ped 11.25 mg 3-month formulations, valued at $23,934.53. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 19, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military and federal healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive portfolio of brand-name and generic medications, vaccines, and medical devices. The DLA's Pharmaceutical Prime Vendor Global Program leverages multiple contractors to support Defense Health Agency and other federal healthcare systems. This delivery order for Lupron Depot-Ped, a pediatric hormonal treatment, exemplifies the company's role in supplying specialized pharmaceutical products to support military healthcare programs worldwide, demonstrating its capability to fulfill federal medical supply requirements across diverse therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9R07?
SPE2DR26F9R07 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F9R07 worth?
The government has obligated $23,935 on SPE2DR26F9R07.
Is contract SPE2DR26F9R07 an order under another contract?
Yes. SPE2DR26F9R07 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9R07 competed?
The extent of competition for SPE2DR26F9R07 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award